期刊文献+

DOG1与胃肠道间质瘤关系的研究进展 被引量:6

Recent advances in relationship between DOG1 and gastrointestinal stromal tumors
原文传递
导出
摘要 FLJ10261(TEME16A)是新近发现的与胃肠道间质瘤(GISTs)关系密切的一个基因,由该基因编码的蛋白质DOG1,特异性表达于GISTs中,免疫组化及原位杂交证实,其阳性表达较KIT和PDGFRA更弥漫、更具有特异性,因此可能作为胃肠道间质瘤治疗的另一个靶点。笔者对DOG1与GISTs关系的研究进展进行综述。 FLJ10261 (TEME16A) is a recently defined gene that is closely related to gastrointestinal stromal tumors (GISTs). The DOG1 protein encoded by this gene is specifically expressed in GISTs, and its positive expression is more extensive and specific than the expressions of KIT and PDGFRA as proved by immunohistochemistry and in situ hybridization. Thus, it may become an alternative therapeutic target for GISTs. This paper reviews the recent advances in the relationship between DOG1 and GISTs.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第10期1287-1290,共4页 China Journal of General Surgery
关键词 胃肠道间质肿瘤 原癌基因蛋白质C-KIT 蛋白酪氨酸激酶类 FLJ10261基因 DOG1 综述文献 Gastrointestinal Stromal Tumors Proto-Oncogene Proteins c-kit Protein-Tyrosine Kinases FLJ10261 Gene D O G 1 Review
  • 相关文献

参考文献8

二级参考文献43

共引文献147

同被引文献80

  • 1Ashwin Rammohan,Jeswanth Sathyanesan,Kamalakannan Rajendran,Anbalagan Pitchaimuthu,Senthil-Kumar Perumal,UP Srinivasan,Ravi Ramasamy,Ravichandran Palaniappan,Manoharan Govindan.A gist of gastrointestinal stromal tumors: A review[J].World Journal of Gastrointestinal Oncology,2013,5(6):102-112. 被引量:30
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:87
  • 3Fern 6 ndez-Esparrach G, Sendino O, So16 M, et al. Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study[J]. Endoscopy, 2010, 42(4):292-299.
  • 4Rossi S, Gasparotto D, Toffolatti L, et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size[J]. Am J Surg Pathol, 2010, 34(10):1480-1491.
  • 5Casali PG, Blay JY. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2010, 21(suppl 5):v98-102.
  • 6Blesius A, Cassier PA, Bertucci F, et al. Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial[J]. BMC Cancer, 2011, 11(1):72.doi: 10.1186/1471- 2407-11-72.
  • 7Eisenberg BL, Smith KD. Adjuvant and neoadjuvant therapy for primary GIST[J]. Cancer Chemother Pharmacol, 2011, 67(supp11):S3-8.
  • 8Raut CP, Posner M, Desai J, et al. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors[J]. J Clin Oncol, 2006, 24(15):2325-2331.
  • 9DeMatteo RP, Maki RG, Singer S, et al. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor[J]. Ann Surg, 2007, 245(3):347-352.
  • 10Mussi C, Ronellenfitsch U, Jakob J, etal. Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?[J]. Ann oncol, 2010, 21 (2):403-408.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部